The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase III study with atezolizumab versus placebo in patients with malignant pleural mesothelioma after pleurectomy/decortication (AtezoMeso study).
 
Maria Pagano
No Relationships to Disclose
 
Marco Alloisio
No Relationships to Disclose
 
Federico Cappuzzo
Honoraria - AstraZeneca/MedImmune; Lilly; MSD Oncology; Pfizer; Roche/Genentech
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; Lilly; MSD Oncology; pfizer; Roche/Genentech; Takeda
Travel, Accommodations, Expenses - OSE Immunotherapeutics
 
Francesco Facciolo
No Relationships to Disclose
 
Paolo Bironzo
Honoraria - AstraZeneca; BeiGene; Bristol-Myers Squibb; MSD Oncology; Roche; Takeda
Speakers' Bureau - AstraZeneca; Roche
Research Funding - Roche (Inst)
Travel, Accommodations, Expenses - Amgen
 
Ugo Pastorino
No Relationships to Disclose
 
Federico Rea
No Relationships to Disclose
 
Armando Santoro
Consulting or Advisory Role - ARQULE; Bayer; Bristol-Myers Squibb; Eisai; Gilead Sciences; Incyte; MSD; Pfizer; Sanofi; SERVIER
Speakers' Bureau - Abbvie; Amgen; ArQule; AstraZeneca; Bayer; BMS; Celgene; Eisai; Gilead Sciences; Lilly; MSD; Novartis; Pfizer; Roche; Sandoz; Servier; Takeda
 
Francesca Zanelli
No Relationships to Disclose
 
Giulia Alberti
No Relationships to Disclose
 
Candida Bonelli
No Relationships to Disclose
 
Erika Gervasi
No Relationships to Disclose
 
Carmine Pinto
No Relationships to Disclose